Showing results (91-100 of 173) with videos related to
Sort By:
Pageof 18
BMC Pharmacology & Toxicology|May 30, 2020
Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedureChristian Siebel, Gudrun Würthwein, Claudia Lanvers-Kaminsky, et al.The New England Journal of Medicine|April 26, 2023
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic LeukemiaInge M van der Sluis, Paola de Lorenzo, Rishi S Kotecha, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 13, 2016
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary TherapyAjay Vora, Anita Andreano, Ching-Hon Pui, et al.Leukemia & Lymphoma|February 1, 2017
Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia - first findings of the OPAL trialKathinka Krull, Marina Kunstreich, Janina Klasen-Sansone, et al.Blood|April 5, 2014
Interleukin-15 enhances cellular proliferation and upregulates CNS homing molecules in pre-B acute lymphoblastic leukemiaMark T S Williams, Yasar Yousafzai, Charlotte Cox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2010
Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005Maurizio Aricò, Martin Schrappe, Stephen P Hunger, et al.Hemasphere|May 8, 2023
The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic LeukemiaAnna Østergaard, Amir Enshaei, Rob Pieters, et al.British Journal of Haematology|October 4, 2007
High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemiaAnja Troeger, Sonja Gudowius, Gabriele Escherich, et al.Blood Advances|November 26, 2019
Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivityFranziska Schramm, Udo Zur Stadt, Martin Zimmermann, et al.Pediatric Blood & Cancer|July 24, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALLMiguel Vieira Martins, Paola de Lorenzo, Rishi S Kotecha, et al.Pageof 18